RPL5P10

Across TCGA pan-cancer cohorts, RPL5P10 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RPL5P10 data layer.

The strongest signal is observed in uveal melanoma (UVM), where higher RPL5P10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPL5P10 expression acts as an unfavorable survival marker, although some lineages such as PAAD and GBM show a favorable association.

UVM, PAAD, and GBM are the cancer types where RPL5P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UVM	DFS	Tertile	All	0.347	0.825	.001	45	view →
PAAD	DFS	Tertile	All	0.907	0.461	.006	36	view →
GBM	OS	Median	All	0.321	0.217	.005	24	view →
ACC	DFS	Tertile	III,IV	0.049	0.399	.001	18	view →
LUSC	OS	Tertile	IV	0.001	0.651	.025	18	view →
UCS	OS	Tertile	III,IV	0.191	0.505	.029	18	view →
KIRP	OS	Tertile	All	1.000	0.664	.030	12	view →
BLCA	DFS	Tertile	IV	0.218	0.499	.037	9	view →
CHOL	DFS	Tertile	All	0.126	0.513	.032	9	view →
LIHC	DFS	Tertile	III,IV	0.158	0.373	.029	9	view →
ESCA	DFS	Tertile	All	1.000	0.583	.030	8	view →
OV	OS	Tertile	All	0.664	0.739	.048	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RPL5P10–UVM (DFS)

Open the UVM breakdown →